Efficacy and Safety of Different Immunosuppressive Therapies in Patients With Membranous Nephropathy and High PLA2R Antibody Titer

Background: This study aimed to evaluate clinical features and prognosis and therapy option of patients with different risk ranks based on antibody against the M-type phospholipase-A2-receptor (PLA2Rab) level in seropositive M-type phospholipase-A2-receptor (PLA2R)-associated membranous nephropathy...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Le, Huang, Qipeng, Wang, Jiang, Luo, Kaiping, Liu, Jiarong, Yan, Wenjun, Jiang, Fang, Xu, Gaosi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801920/
https://www.ncbi.nlm.nih.gov/pubmed/35111055
http://dx.doi.org/10.3389/fphar.2021.786334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801920/
https://www.ncbi.nlm.nih.gov/pubmed/35111055
http://dx.doi.org/10.3389/fphar.2021.786334

Ejemplares similares